LONGITUDINAL ANALYSIS OF PATIENT LEVEL HEALTH CARE COSTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE

被引：0
|
作者：
Cui, Z. [1 ]
Faries, D. E. [1 ]
Shen, W. [1 ]
Able, S. L. [1 ]
Novick, D. [2 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Windlesham, Surrey, England
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.803
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A335 / A336
页数：2
相关论文
共 50 条
  • [41] Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder
    Ta, Jamie T.
    Sullivan, Sean D.
    Tung, Amy
    Oliveri, David
    Gillard, Patrick
    Devine, Beth
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (02): : 223 - 239
  • [42] Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment
    Broder, Michael S.
    Greene, Mallik
    Yan, Tingjian
    Chang, Eunice
    Hartry, Ann
    Yermilov, Irina
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (02) : 221 - 232
  • [43] ADHERENCE TO DULOXETINE AND HOSPITAL UTILIZATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER AND CHRONIC PAIN
    Wang, J.
    Liu, X.
    Mullins, C. D.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A128 - A128
  • [44] Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder
    Perahia, DG
    Kajdasz, DK
    Desaiah, D
    Haddad, PM
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2005, 89 (1-3) : 207 - 212
  • [45] Duloxetine for the treatment of major depressive disorder in patients age ≥ 55, 1:: Efficacy
    Kennedy, JS
    Mallinckrodt, CH
    Tran, PV
    Wohlreich, MM
    Detke, MJ
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1068 - 1069
  • [46] Efficacy of duloxetine treatment for anxiety in elderly patients with major depressive disorder.
    Russell, J.
    Raskin, J.
    Wiltse, C.
    Walker, D.
    Piezer, K.
    Brawman-Mintze, O.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S119 - S120
  • [47] Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials
    Lam, Raymond W.
    Andersen, Henning F.
    Wade, Alan G.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 181 - 187
  • [48] Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature
    Mancini, Michele
    Perna, Giampaolo
    Rossi, Andrea
    Petralia, Antonino
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1167 - 1181
  • [49] Duloxetine for the treatment of major depressive disorder in patients aged ≥55:: Meta-analysis of safety data
    Mallinckrodt, CH
    Kennedy, JS
    Tran, PV
    Hurley, DJ
    Wohlreich, MM
    Demitrack, MA
    Detke, MJ
    [J]. PSYCHOSOMATICS, 2003, 44 (02) : 139 - 139
  • [50] Factors associated with duloxetine treatment among patients with major depressive disorder in Veterans Health Administration: a retrospective study
    Shi, Lizheng
    Liu, Jinan
    Campbell, Claudia
    Zhao, Yang
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (12) : 2715 - 2721
12345